Expertise in
11
conditions

Dr. Melanie K. Bergman

Oncology
Providence
101 West 8th Avenue, Suite 1400, 
Spokane, WA 
Accepting New Patients
Offers Telehealth
Expertise in
11
conditions
Providence
101 West 8th Avenue, Suite 1400, 
Spokane, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Melanie Bergman is an Oncologist in Spokane, Washington. Dr. Bergman is highly rated in 11 conditions, according to our data. Her top areas of expertise are Endometrial Cancer, Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Ureteral Reconstruction, and Salpingo-Oophorectomy. Dr. Bergman is currently accepting new patients.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Obstetrics & Gynecology in WA
Hospital Affiliations
Providence Holy Family Hospital
Prov Sacred Hrt Med Ctr & Childs Hosp.
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

101 West 8th Avenue, Suite 1400, Spokane, WA 99204
Call: 509-474-2200

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I/II Study Evaluating the Dosing, Safety, Efficacy, and Biological Activity of Intraperitoneal IMNN-001 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered in Combination With Neoadjuvant Chemotherapy (NACT) in Patients Newly Diagnosed With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A Phase I/II Study Evaluating the Dosing, Safety, Efficacy, and Biological Activity of Intraperitoneal IMNN-001 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered in Combination With Neoadjuvant Chemotherapy (NACT) in Patients Newly Diagnosed With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 05, 2025
Intervention Type: Drug, Biological
Study Drugs: GEN-1, Carboplatin, Paclitaxel
Study Phase: Phase 1/Phase 2
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: October 29, 2025
Intervention Type: Biological
Study Drug: Dostarlimab
Study Phase: Phase 1
A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody-Drug Conjugate (ADC), in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers
A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody-Drug Conjugate (ADC), in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Drug
Study Drug: STRO-002
Study Phase: Phase 1
View 2 Less Clinical Trials

3 Total Publications

Corrigendum to 'OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer' [Gynecol Oncol 2025 Jun 197 182-191].
Corrigendum to 'OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer' [Gynecol Oncol 2025 Jun 197 182-191].
Journal: Gynecologic oncology
Published: November 07, 2025
View All 3 Publications
Similar Doctors
Expertise in
10
conditions
Dr. Elizabeth A. Grosen
Oncology
Expertise in
10
conditions
Dr. Elizabeth A. Grosen
Oncology
101 West 8th Avenue, Suite 1400, 
Spokane, WA 
 (0.1 miles away)
509-474-2200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Elizabeth Grosen is an Oncologist in Spokane, Washington. Dr. Grosen is highly rated in 10 conditions, according to our data. Her top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Bladder Reconstruction, and Salpingo-Oophorectomy. Dr. Grosen is currently accepting new patients.

Expertise in
12
conditions
Dr. Kristine J. Rinn
Oncology
Expertise in
12
conditions
Dr. Kristine J. Rinn
Oncology
1204 North Vercler Road, 
Spokane Valley, WA 
 (9.5 miles away)
509-228-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kristine Rinn is an Oncologist in Spokane Valley, Washington. Dr. Rinn is highly rated in 12 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Rinn is currently accepting new patients.

Expertise in
50
conditions
Dr. Mark E. Sienko
Oncology | Hematology | Hematology Oncology
Expertise in
50
conditions
Dr. Mark E. Sienko
Oncology | Hematology | Hematology Oncology

Multicare Health System

910 W 5th Ave, 
Spokane, WA 
 (0.6 miles away)
Languages Spoken:
English, Korean, Mandarin, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Sienko is an Oncologist and a Hematologist in Spokane, Washington. Dr. Sienko is highly rated in 50 conditions, according to our data. His top areas of expertise are Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Sienko is currently accepting new patients.

VIEW MORE Oncologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bergman's expertise for a condition
ConditionClose
    • Distinguished
    • Endometrial Cancer
      Dr. Bergman is
      Distinguished
      . Learn about Endometrial Cancer.
      See more Endometrial Cancer experts
    • Malignant Mixed Mullerian Tumor
      Dr. Bergman is
      Distinguished
      . Learn about Malignant Mixed Mullerian Tumor.
      See more Malignant Mixed Mullerian Tumor experts
    • Ovarian Cancer
      Dr. Bergman is
      Distinguished
      . Learn about Ovarian Cancer.
      See more Ovarian Cancer experts
    • Ovarian Carcinosarcoma
      Dr. Bergman is
      Distinguished
      . Learn about Ovarian Carcinosarcoma.
      See more Ovarian Carcinosarcoma experts
    • Sertoli-Leydig Cell Tumor
      Dr. Bergman is
      Distinguished
      . Learn about Sertoli-Leydig Cell Tumor.
      See more Sertoli-Leydig Cell Tumor experts
    • Testicular Yolk Sac Tumor
      Dr. Bergman is
      Distinguished
      . Learn about Testicular Yolk Sac Tumor.
      See more Testicular Yolk Sac Tumor experts
    View All 7 Distinguished Conditions
    • Advanced
    • Cervical Cancer
      Dr. Bergman is
      Advanced
      . Learn about Cervical Cancer.
      See more Cervical Cancer experts
    • Ureteral Reconstruction
      Dr. Bergman is
      Advanced
      . Learn about Ureteral Reconstruction.
      See more Ureteral Reconstruction experts
    • Vaginal Cancer
      Dr. Bergman is
      Advanced
      . Learn about Vaginal Cancer.
      See more Vaginal Cancer experts
    • Vulvar Cancer
      Dr. Bergman is
      Advanced
      . Learn about Vulvar Cancer.
      See more Vulvar Cancer experts
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Bergman is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Angiomyoma
      Dr. Bergman is
      Experienced
      . Learn about Angiomyoma.
      See more Angiomyoma experts
    • Desmoplastic Small Round Cell Tumor
      Dr. Bergman is
      Experienced
      . Learn about Desmoplastic Small Round Cell Tumor.
      See more Desmoplastic Small Round Cell Tumor experts
    • Eccrine Porocarcinoma
      Dr. Bergman is
      Experienced
      . Learn about Eccrine Porocarcinoma.
      See more Eccrine Porocarcinoma experts
    • Hernia Surgery
      Dr. Bergman is
      Experienced
      . Learn about Hernia Surgery.
      See more Hernia Surgery experts
    • Melanoma
      Dr. Bergman is
      Experienced
      . Learn about Melanoma.
      See more Melanoma experts
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Oncologists Spokane, WA
    3. Dr. Melanie K. Bergman
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.